With only two weeks left of U.S. Congress in session, a final push for a consensus on healthcare is underway. Both Democrats and Republicans ...

After a year of progress, scientists say they are on the cusp of turning AI-designed antibodies into potential therapies. In ...

Representing a variety of public and private sectors, guests from technology and finance to education and the ...

As the U.S. government turns its attention to drug cartels in Mexico, new research from the University of California, Davis, ...

Congressional researchers say it “remains unclear” how the federal government might enforce a newly enacted law that takes ...

Democratic senators have introduced a new bill to create a federal regulatory framework for hemp-derived cannabinoids and ...

President Donald Trump road-tested his claims that he’s tackling Americans’ affordability woes at a Tuesday rally in Mount ...

The rally, focused on affordability, comes as polling consistently shows that public trust in President Trump’s economic ...

Good morning, everyone, and welcome to Ligand's 2025 Investor Day. I'm Melanie Herman, Head of Investor Relations for Ligand. And on behalf of our entire team, I'd like to thank you for taking the ...

Eric Topol certainly thinks so. The cardiologist, vice president of Scripps Research, and author of Super Agers is convinced ...

The Future of Life Institute assigned letter grades to eight leading AI labs to score their safety efforts. The results look ...

Discover Kodiak's focused pipeline and late-stage trials advancing retinal disease therapies. Learn why KOD stands out in ...